These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 885264)

  • 1. Modulation of host immune response against the L2C guinea pig leukemia.
    Klein DL; Pearson JW
    Fed Proc; 1977 Aug; 36(9):2276-80. PubMed ID: 885264
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of immunotherapy to enhance tumor rejection immunity in leukemic (L2C) guinea pigs following remission induction with MeCCNU.
    Klein DL; Cote P; Garner W; Wallen RM; Pearson JW
    Leuk Res; 1980; 4(1):185-95. PubMed ID: 7412356
    [No Abstract]   [Full Text] [Related]  

  • 3. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG-immunotherapy of L2C guinea pig leukemia.
    Dopatka HD; Majer M; Freudenstein H; Hennessen W
    Dev Biol Stand; 1977 Apr 13-15; 38():355-8. PubMed ID: 608523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 9. L2C guinea pig leukemia. A potential model for structuring multimodality therapy.
    Murphy S
    Isr J Med Sci; 1978 Jan; 14(1):20-37. PubMed ID: 632081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemia.
    Dopatka HD; Majer M; Hennessen W; Mauler R
    Dev Biol Stand; 1977 Apr 13-15; 38():359-62. PubMed ID: 608524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies of the guinea pig L2C leukemia.
    Green I; Forni G; Konen T; Hu CP; Schwartz BD; Kask A; Shevach EM
    Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization of guinea pigs against L2C leukemia with live leukemic cells by intradermal inoculation: early and late effects.
    Gross L; Dreyfuss Y
    Fed Proc; 1977 Aug; 36(9):2272-6. PubMed ID: 885263
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro cytotoxic effect of guinea-pig natural killer cells (Kurloff cells) on homologous leukemic cells (L2C).
    Debout C; Birebent B; Griveau AM; Izard J
    Leukemia; 1993 May; 7(5):733-5. PubMed ID: 8483326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor immunity in strain 2 guinea pigs immunized with potassium chloride extracts of L2C tumor cells.
    Braun DP; Hengst JC; Mokyr MB; Dray S
    J Natl Cancer Inst; 1978 Apr; 60(4):899-903. PubMed ID: 344900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and partial characterization of a tumor-associated transplantation antigen of the guinea pig L2C leukemia.
    Hu CP; Konen TG; Hoes C; Green I
    J Immunol; 1978 May; 120(5):1521-5. PubMed ID: 77874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
    Levy JP; Kourilsky FM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG-immunotherapy of L2C-guinea pig leukemia.
    Dopatka HD; Majer M; Freudenstein H
    Eur J Cancer (1965); 1978 Feb; 14(2):169-81. PubMed ID: 624313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.